Survival and progression of HIV disease in women attending GUM/HIV clinics in Britain and Ireland

Sexually Transmitted Infections

Volumn 75, Issue 4, 1999, Pages 247-252

  Stephenson, Judith ^a   Stephenson, J M ^k   Griffioen, A ^k   Woronnowski, H ^k   Phillips, A N ^k   Petruckevitch, A ^k   Keenlyside, R ^k   Johnsons, A M ^k   Anderson, J ^k   Melville, R ^k   Jeffries, D J ^k   Norman, J ^k   Barton, S ^b   Chard, S ^b   Sibley, K ^b   Mitchelmore, M ^b   Brettle, R ^c   Morris, S ^c   O'Dornen, P ^c   Russel, J ^k   Overington Hickford, L ^k   O'Farrell, N ^d   Chappel, J ^d   Mulcahy, R F ^e   Moseley, J ^e   Lyons, F ^e   Welch, J ^k   Graham, D ^k   Fadojurmi, M ^k   Kithchen, V ^f   Wells, C ^f   Byrne, G ^f   Tobin, J ^g   Tucker, L ^g   Harindra, V ^g   Mercey, D E ^k   Allason Jones, E ^k   Campbell, I ^k   French, R ^k   Johnson, M A ^k   Reid, A ^k   Farmer, D ^k   Saint, N ^k   Olaitan, A ^k   Madge, S ^k   Forster, G ^k   Phillips, M ^k   Sampson, K ^k   Nayagam, A ^h,i   Edlin, J ^h   Bradbeer, C ^j   De Ruiter, A ^j   Hargreaves, L ^j   Doyle, C ^j   more..

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

^c CITY HOSPITAL   (United Kingdom)

^d GUY S HOSPITAL   (United Kingdom)

^e ST JAMES S HOSPITAL   (Ireland)

^f ST MARY S HOSPITAL   (United Kingdom)

^g ST MARY S HOSPITAL   (United Kingdom)

^h ROYAL SUSSEX COUNTY HOSPITAL   (United Kingdom)

ⁱ UK   (United Kingdom)

^j ST THOMAS HOSPITAL   (United Kingdom)

^k NONE

more..

Author keywords

AIDS; Cohort study; Ethnic group; HIV infection; Survival; Women

Indexed keywords

ORAL CONTRACEPTIVE AGENT;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; CANDIDIASIS; CIGARETTE SMOKING; DEATH; DISEASE COURSE; DISEASE TRANSMISSION; ETHNIC DIFFERENCE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IRELAND; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; PNEUMOCYSTIS PNEUMONIA; PRIORITY JOURNAL; RISK FACTOR; SURVIVAL RATE; UNITED KINGDOM;

EID: 0032823435     PISSN: 13684973     EISSN: None     Source Type: Journal    
DOI: 10.1136/sti.75.4.247     Document Type: Article

References (33)

1. 1 Rutherford GW, Lifson AR, Hessol NA, et al. Course of HIV-1 infection in a cohort of homosexual and bisexual men: an 11 year follow up study. BMJ 1990;301:1183-8.
2. 2 Prins M, Veugelers J, European Seroconverter Study and the Tricontinental Seroconverter Study, Comparison of progression and non-progressionin injecting drug users and homosexual men with documented dates of HIV-1 seroconversion. AIDS 1997;11:621-31.
3. 3 Selwyn PA, Alcabes P, Hartel D, et al. Clinical manifestations and predictors of disease progression in drug users with human immunodeficiency virus infection. N Engl J Med 1992;327:1697-703.
4. 4 Darby SC, Ewart DW, Giangrande PLF, et al , UK Haemophilia Centre Directors Organisation. Importance of age at infection with HIV-1 for survival and development of AIDS in UK haemophilia population. Lancet 1996;347:1573-8.
5. 5 PHLS AIDS Centre, Scottish Centre for Infection and Environmental Health. AIDS/HIV quarterly surveillance tables. 1998;No 41.
6. 6 Centers for Disease Control. Diagnosis and reporting of HIV and AIDS in states with integrated HIV and AIDS surveillance - United States, January 1994-June 1997. MMWR 1998;47:309-14.
7. 7 Cozzi-Lepri A, Pezzotti P, Dorrucci M, et al. HIV disease progression in 854 women and men infected through injecting drug use und heterosexual sex and followed up for up to nine years from seroconversion. Italian Seroconversion Study. BMJ 1994;309:1537-42.
8. 8 The Terry Beirn Community Programs for Clinical Research on AIDS, Melnick SL, Sherer R, et al. Survival and disease progression according to gender of patients with HIV infection. JAMA 1994;272:1915-21.
9. 9 Morlat P, Parneix P, Douard D, et al. Women and HIV infection: a cohort study of 483 HIV-infected women in Bordeaux, France, 1985-1991. AIDS 1992;6: 1187-98.
10. 10 Smith DK, Warren DL, Viahov D, et al. Design and baseline participant characteristics of the human immunodeficiency virus epidemiology research (HER) study: a prospective cohort study of human immunodeficiency virus infection in US women. Am J Epidemiol 1997;146: 459-69.
11. 11 von Overbeck J, Egger M, Davey Smith G, et al. Survival in HIV infection: do sex and category of transmission matter? AIDS 1994;8:1307-13.
12. 12 The Study Group for the MRC Collaborative Study of HIV infection in Women. Ethnic differences in women with HIV infection in Britain and Ireland. AIDS 1996;10:89-93.
13. 13 Mellors JW, Munoz A, Giorgi JV, et al. Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection. Ann Intern Med 1997;126:946-54.
14. 14 Pezzotti P, Phillips AN, Dorrucci M, et al. Category of exposure to HIV and age in the progression to AIDS: longitudinal study of 1199 people with known dates of seroconversion. BMJ 1996;313:583-6.
15. 15 Chaisson RE, Keruly JC, Moore RD. Race, sex, drug use, and progression of human immunodeficiency virus disease. N Engl J Med 1995;333:751-6.
16. 16 Maini MK, Gilson RJC, Chavda N, et al. Reference ranges and sources of variability of CD4 counts in HIV-seronegative women and men. Genitourin Med 1996;72: 27-31.
17. 17 Lee CA, Phillips AN, Elford J, et al. Progression of HIV disease in a haemophilic cohort followed for 11 years and the effect of treatment. BMJ 1991;303:1093-6.
18. 18 Editorial. Women: absent term in the AIDS research equation. Science 1995;269:777-80.
19. 19 Mercey D, Griffioen A, Woronowski H, et al, and the Study Group for the MRC Collaborative Study of HIV Infection in Women. Uptake of medical interventions in women with HIV infection in Britain and Ireland. Genitourin Med 1996; 72:281-2.
20. 20 Del Amo J, Petruckevitch A, Phillips A, et al. Disease progression and survival in HIV-1 infected Africans in London. AIDS 1998;12:1203-9.
21. 21 Sterk CE. Women and AIDS: a brief update. Int J STD AIDS 1999;9:16-18.
22. 22 Sha BE, Benson CA, Pottage JC, et al. HIV infection in women: an observational study of clinical characteristics, disease progression and survival for a cohort of women in Chicago. J Acquir Immune Defic Syndr 1995;8:486-95.
23. 23 Clark RA, Blakley SA, Rice R, et al. Predictors of HIV disease progression in women. J Acquir Immune Defic Syndr 1995;9:43-50.
24. 24 Ward JW, Bush TJ, Perkins HA, et al. The natural history of transfusion-associated infection with human immunodeficiency virus. N Engl J Med 1989;321:947-52.
25. 25 Gazzard B, Moyle G, BHIVA Guidelines Co-ordinating Committee. 1998 revision to the British HIV association guidelines for antiretroviral treatment of HIV seropositive individuals. Lancet 1998;352:314-16.
26. 26 Hogg RS, Heath KV, Yip B, et al. Improved survival among HIV-infected individuals following initiation of antiretroviral therapy. JAMA 1998;11:450-4.
27. 27 Lindan CP, Allen S, Serufilira A, et al. Predictors of mortality among HIV-infected women in Kigali, Rwanda. Ann Intern Med 1992;116:320-8.
28. 28 Mulder DW, Nunn AJ, Kamali A, et al. Two-year HIV-1-associated mortality in a Ugandan rural population. Lancet 1994;343:1021-3.
29. 29 Hogg RS, Strathdee SA, Craib KJP, et al. Lower socioeconomic status and shorter survival following HIV infention. Lancet 1994;344:1120-4.
30. 30 Craib KJP, Schechter MT, Montaner JSG, et al. The effect of cigarette smoking on lymphocyte subsets and progression to AIDS in a cohorts of homosexual men. Clin Invest Med 1992;15:301-8.
31. 31 Burns DN, Hillman D, Neaton JD, et al. Cigarette smoking, bacterial pneumonia and other clinical outcomes in HIV-1 infection. J Acquir Immune Defic Syndr 1996;13:374-83.
32. 32 Clark RA, Bessinger R. Clinical manifestations and predictors of survival in older women infected with HIV. J Acquir Immune Defic Syndr 1997;15:341-5.
33. 33 Stephenson JM. Systematic review of hormonal contraception and risk of HIV transmission: when to resist meta-analysis. AIDS 1998;12:545-53.